Skip to content
Evofem Biosciences, Inc.
About Us
Mission
Management
Board of Directors
Saundra Pelletier
KIM P. KAMDAR, Ph.D.
Tony O’Brien
Lisa Rarick, MD, FACOG
Colin Rutherford
Our Products
phexxi
®
Solosec
®
Publications
Investors
Investor Overview
Events & Presentations
Press Releases
Stock Information
Financial Information
SEC Filings
Analyst Coverage
Corporate Governance
Committee Composition
Board of Directors
Charters + Code of Ethics
Investor Resources
Investor Contact
Investor FAQs
Contact
Investor Contact
Media Contact
General Contact
Careers
Efficacy and Safety of Vaginal pH Regulator for Prevention of Chlamydia and Gonorrhea
Post navigation
Previous:
A Novel Vaginal pH Regulator: Results From The Phase 3 AMPOWER Contraception Clinical Trial
Next:
Perfect-Use Pregnancy Rates with Vaginal pH Regulator: Efficacy Results from AMPOWER
Back
to
Top
